Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 6 minute read Pharma Industry News KalVista Pharmaceuticals wins EU and Swiss approval for EKTERLY—what does this mean for the stock? KalVista Pharmaceuticals secures EU and Swiss approval for EKTERLY, the first oral HAE therapy. Can this rare disease breakthrough lift KALV stock? byPallavi MadhirajuSeptember 19, 2025